• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-TGFBI / BIGH3

TGFBI / BIGH3 Monoclonal Antibody for WB, IHC, IF-P, IP, Indirect ELISA

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain

Applications

WB, IHC, IF-P, IP, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

3E11D11

N° de cat : 60007-1-PBS

Synonymes

TGFBI, 3E11D11, Beta ig h3, Beta ig-h3, BIGH3



Informations sur le produit

60007-1-PBS cible TGFBI / BIGH3 dans les applications de WB, IHC, IF-P, IP, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Mouse / IgG2a
Clonalité Monoclonal
Type Anticorps
Immunogène TGFBI / BIGH3 Protéine recombinante Ag0241
Nom complet transforming growth factor, beta-induced, 68kDa
Masse moléculaire calculée 683 aa, 75 kDa
Poids moléculaire observé 68 kDa
Numéro d’acquisition GenBankBC000097
Symbole du gène TGFBI
Identification du gène (NCBI) 7045
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Précipitation de l'acide caprylique/du sulfate d'ammonium
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

TGFBI, also named as BIGH3, Kerato-epithelin and RGD-CAP, binds to type I, II, and IV collagens. TGFBI is an adhesion protein which may play an important role in cell-collagen interactions. In cartilage, it may be involved in endochondral bone formation. TGFBI is an extracellular matrix adaptor protein, it has been reported to be differentially expressed in transformed tissues. TGFBI is a predictive factor of the response to chemotherapy, and suggest the use of TGFBI-derived peptides as possible therapeutic adjuvants for the enhancement of responses to chemotherapy.(PMID:20509890) Defects in TGFBI are the cause of epithelial basement membrane corneal dystrophy (EBMD). Defects in TGFBI are the cause of corneal dystrophy Groenouw type 1 (CDGG1). Defects in TGFBI are the cause of corneal dystrophy lattice type 1 (CDL1). Defects in TGFBI are a cause of corneal dystrophy Thiel-Behnke type (CDTB). Defects in TGFBI are the cause of Reis-Buecklers corneal dystrophy (CDRB). Defects in TGFBI are the cause of lattice corneal dystrophy type 3A (CDL3A). Defects in TGFBI are the cause of Avellino corneal dystrophy (ACD).

{{ptg:RelatedPrimaryAntibodies}}